If you missed Indaptus Therapeutics, Inc. CEO, Jeffrey Meckler's presentation after our November event, here is your chance to catch it online. A very timely topic.
Join us for an exclusive Tribe Public CEO Presentation and Q&A Webinar on Monday, March 17 at 12pm ET. Our events are concise (approx. 30 mins), limited to 500 seats, and offer the opportunity to engage with experts and leaders from companies you care about, no matter where you are. Title: "Keys To The Kingdom: Unlocking the Power of Your Immune System" ?? REGISTER TODAY: INDP-KEYS.TribePublic.com Meet Jeffrey Meckler, CEO of Indaptus Therapeutics (NASDAQ: INDP), a company leveraging immune responses to combat diseases and recently announced a clinical supply agreement with #BeiGene (NASDAQ: ONC). Jeffrey will present and engage in a 5-10 minute Q&A session. Send your questions to [email protected] or via Zoom chat during the event. Speaker Background: ?? Jeffrey Meckler, CEO of Indaptus Therapeutics (NASDAQ: INDP), brings over 30 years of financial and healthcare leadership. Formerly CEO of Intec Pharma and Cocrystal Pharma, Jeff has a diverse background including roles at Pfizer. He holds degrees from Carnegie Mellon University and Fordham University School of Law. Don't miss this opportunity to learn from industry experts this St. Patrick's Day! ?? #TribePublic #CEOEvent #HealthcareLeadership #CarnegieMellon #TravereTherapeutics #Pfizer #BellevueHospital